Blood cell ratio may flag heart danger in kidney dialysis patients
NCT ID NCT07519785
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether the ratio of two types of blood cells (platelets and lymphocytes) can predict heart complications in people on long-term dialysis. Researchers followed 80 dialysis patients to see if this simple blood test ratio was linked to problems like hardening of the arteries. The goal was to find an easy, low-cost way to identify patients at higher risk.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If this blood test ratio proves useful, it could give doctors a simple, low-cost way to identify dialysis patients at higher risk for heart problems.
What could go wrong
This is a small, completed observational study, not a treatment trial. The findings need to be confirmed in larger, more diverse groups before they can change medical practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR COMPLICATIONS IN HEMODIALYSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kiriazy
Minya, Elminya, 2422998, Egypt